A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Quality Control Analyst 2

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeNorton, MA, USA$75k - $101.4k

About the Job

Requirements

  • A bachelor's degree in chemistry, biology, biochemistry, or a related scientific field is required.
  • Four to eight years of pharmaceutical or biotechnology industry experience in a GMP Quality Control function or equivalent relevant industry experience is required.
  • Experience in method transfer and/or analytical method implementation is required; understanding of method lifecycle management and a phase-appropriate approach is desirable.
  • Technical writing skills are required; technical writing of investigations is preferred.
  • Proficiency in data analysis and interpretation is required.
  • Problem-solving skills and experience conducting investigations and implementing corrective and preventive actions are required.
  • Organizational skills and the ability to manage multiple tasks simultaneously and autonomously are required.
  • Proficiency in LabWare LIMS, Excel, Word, and PowerPoint is preferred.

Responsibilities

  • Perform routine and non-routine analytical testing, preferably HPLC/UPLC and/or microbiological assays, to support raw materials, in-process samples, product release, and stability studies while following established standard operating procedures.
  • Support weekend laboratory operations in Analytical, Microbiology, and Raw Materials to maintain a continuous operational schedule.
  • Maintain current training records, adhere to the testing schedule, and complete assignments on time to support QC operations, project timelines, and quality metrics.
  • Assist with laboratory equipment and inventory maintenance, including preparing reagents and samples.
  • Review data in a timely manner and qualify as a data reviewer to support timely data availability.
  • Perform role-specific operational assignments, such as raw material processes including SAP transactions, environmental monitoring, and in-process testing.
  • Revise and update controlled documents, including standard operating procedures, work instructions, and test methods, to support continuous improvement and compliance with industry and regulatory requirements.
  • Follow internal standards, policies, and standard operating procedures, as well as regulatory and industry standards including GMP, GLP, and ICH guidelines.
  • Identify and suggest improvements to methods and laboratory processes, particularly those related to efficiency and reliability.
  • Collaborate with QC and cross-functional teams to support quality control operations.
  • Pursue training and development in QC testing techniques, TOQ operations, and regulatory compliance.
  • Assist with technical documentation for regulatory submissions by verifying data and ensuring accuracy and compliance with regulatory standards.
  • Participate in inspection-readiness activities and support onsite audits and inspections as needed.
  • Participate in initiatives to improve QC processes and procedures and increase laboratory efficiency and effectiveness.
  • Collaborate with CMC Development, Manufacturing, Manufacturing Technical Services, Materials Management, and Quality Assurance to support alignment with business goals.

Desired Qualifications

  • Understanding of method lifecycle management and a phase-appropriate approach.
  • Technical writing experience focused on investigations.
  • Proficiency in LabWare LIMS, Excel, Word, and PowerPoint.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs